Overview

The marketing authorisation for BTVPUR AlSap 1 has been withdrawn at the request of the marketing-authorisation holder.

български (BG) (273.86 KB - PDF)

View

español (ES) (219.81 KB - PDF)

View

čeština (CS) (279.88 KB - PDF)

View

dansk (DA) (215.41 KB - PDF)

View

Deutsch (DE) (241.24 KB - PDF)

View

eesti keel (ET) (244.85 KB - PDF)

View

ελληνικά (EL) (281.98 KB - PDF)

View

français (FR) (242.72 KB - PDF)

View

italiano (IT) (215.09 KB - PDF)

View

latviešu valoda (LV) (257.92 KB - PDF)

View

lietuvių kalba (LT) (242.99 KB - PDF)

View

magyar (HU) (257.59 KB - PDF)

View

Malti (MT) (287.39 KB - PDF)

View

Nederlands (NL) (215.61 KB - PDF)

View

polski (PL) (262.68 KB - PDF)

View

português (PT) (215.81 KB - PDF)

View

română (RO) (264.84 KB - PDF)

View

slovenčina (SK) (263.85 KB - PDF)

View

slovenščina (SL) (271.89 KB - PDF)

View

Suomi (FI) (214.4 KB - PDF)

View

svenska (SV) (215.45 KB - PDF)

View

Product information

български (BG) (1.59 MB - PDF)

View

español (ES) (959.08 KB - PDF)

View

čeština (CS) (1.31 MB - PDF)

View

dansk (DA) (976.46 KB - PDF)

View

Deutsch (DE) (1.05 MB - PDF)

View

eesti keel (ET) (962.08 KB - PDF)

View

ελληνικά (EL) (1.63 MB - PDF)

View

français (FR) (969.67 KB - PDF)

View

hrvatski (HR) (995.44 KB - PDF)

View

íslenska (IS) (1.21 MB - PDF)

View

italiano (IT) (409.73 KB - PDF)

View

latviešu valoda (LV) (588.19 KB - PDF)

View

lietuvių kalba (LT) (480.92 KB - PDF)

View

magyar (HU) (1.31 MB - PDF)

View

Malti (MT) (596.85 KB - PDF)

View

Nederlands (NL) (355.82 KB - PDF)

View

norsk (NO) (410.45 KB - PDF)

View

polski (PL) (595.12 KB - PDF)

View

português (PT) (421.48 KB - PDF)

View

română (RO) (479.93 KB - PDF)

View

slovenčina (SK) (582.8 KB - PDF)

View

slovenščina (SL) (563.67 KB - PDF)

View

Suomi (FI) (942.5 KB - PDF)

View

svenska (SV) (419.01 KB - PDF)

View

Latest procedure affecting product information: R/0005

08/09/2015

български (BG) (237.24 KB - PDF)

View

español (ES) (179.61 KB - PDF)

View

čeština (CS) (214.8 KB - PDF)

View

dansk (DA) (168.71 KB - PDF)

View

Deutsch (DE) (181.32 KB - PDF)

View

eesti keel (ET) (216.18 KB - PDF)

View

ελληνικά (EL) (224.9 KB - PDF)

View

français (FR) (168.45 KB - PDF)

View

hrvatski (HR) (203.36 KB - PDF)

View

íslenska (IS) (171.81 KB - PDF)

View

italiano (IT) (166.05 KB - PDF)

View

latviešu valoda (LV) (222.44 KB - PDF)

View

lietuvių kalba (LT) (215.2 KB - PDF)

View

magyar (HU) (208.44 KB - PDF)

View

Malti (MT) (226.37 KB - PDF)

View

Nederlands (NL) (169.29 KB - PDF)

View

norsk (NO) (166.89 KB - PDF)

View

polski (PL) (215.44 KB - PDF)

View

português (PT) (180.94 KB - PDF)

View

română (RO) (212.26 KB - PDF)

View

slovenčina (SK) (211.23 KB - PDF)

View

slovenščina (SL) (210.68 KB - PDF)

View

Suomi (FI) (168.59 KB - PDF)

View

svenska (SV) (168.12 KB - PDF)

View

Product details

Name of medicine
BTVPUR AlSap 1
Active substance
bluetongue-virus serotype-1 antigen
International non-proprietary name (INN) or common name
bluetongue-virus serotype-1 antigen
Species
  • Sheep
  • Cattle
Anatomical therapeutic chemical veterinary (ATCvet) code
QI04AA02

Pharmacotherapeutic group

Immunologicals

Therapeutic indication

Active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotype 1.

Onset of immunity has been demonstrated three weeks after the primary vaccination course. The duration of immunity for cattle and sheep is one year after the primary vaccination course.

Authorisation details

EMA product number
EMEA/V/C/002230
Marketing authorisation holder
Merial

29 Avenue Tony Garnier
69007 Lyon
France

Marketing authorisation issued
17/12/2010
Revision
4

Assessment history

This page was last updated on

Share this page